Department of Pharmaceutics, Gupta College of Technological Sciences, Ashram More, G.T. Road, Asansol-713301 West Bengal, India.
Acta Pharm. 2011 Sep 1;61(3):257-70. doi: 10.2478/v10007-011-0022-6.
In this study, xanthan gum-facilitated ethyl cellulose microsponges were prepared by the double emulsification technique and subsequently dispersed in a carbopol gel base for controlled delivery of diclofenac sodium to the skin. Scanning electron microscopy revealed the porous, spherical nature of the microsponges. Increase in the drug/polymer ratio (0.4:1, 0.6:1, 0.8:1, m/m) increased their yield (79.1-88.5%), drug entrapment efficiency (50.0-64.1%), and mean particle diameter (181-255 μm). Compared to the microsponges with high drug/polymer ratio (0.8:1, m/m), the flux of entrapped drug through excised rat skin decreased by 19.9% and 17.0%, respectively, for the microsponges prepared at low and intermediate drug/polymer ratios. When an equivalent amount of pure drug (not entrapped into microsponges) was dispersed into the gel base and the flux was compared, the microsponges (drug/polymer ratio 0.8:1, m/m) were found to reduce the flux by 33.3%. Whether the drug was dispersed either in un-entrapped or entrapped form into the gel base, the drug permeation through rat skin followed Higuchi's diffusion kinetic model. The microsponges prepared at the lowest drug/polymer ratio exhibited a comparatively slower drug permeation profile and were hence considered most suitable for controlled drug delivery application. FTIR spectroscopy and DSC analyses indicated the chemically stable, amorphous nature of the drug in these microsponges. The gel containing these optimized microsponges was comparable to that of a commercial gel formulation and did not show serious dermal reactions. Hence, the microsponge system obtained at the lowest drug/polymer ratio could be useful for controlled release of diclofenac sodium to the skin.
在这项研究中,通过双重乳化技术制备了黄原胶促进的乙基纤维素微球,然后将其分散在卡波姆凝胶基质中,以控制双氯芬酸钠向皮肤的递送。扫描电子显微镜显示微球具有多孔、球形的性质。随着药物/聚合物比(0.4:1、0.6:1、0.8:1,m/m)的增加,其收率(79.1-88.5%)、药物包封效率(50.0-64.1%)和平均粒径(181-255μm)也随之增加。与高药物/聚合物比(0.8:1,m/m)的微球相比,药物/聚合物比为低和中值(0.4:1 和 0.6:1,m/m)的微球通过离体大鼠皮肤的药物通量分别降低了 19.9%和 17.0%。当将等量的纯药物(未包封入微球中)分散到凝胶基质中并比较通量时,发现微球(药物/聚合物比 0.8:1,m/m)使通量降低了 33.3%。无论药物是以未包封还是包封的形式分散在凝胶基质中,药物通过大鼠皮肤的渗透都遵循 Higuchi 扩散动力学模型。在最低药物/聚合物比下制备的微球表现出相对较慢的药物渗透曲线,因此被认为最适合用于控制药物释放应用。FTIR 光谱和 DSC 分析表明,这些微球中药物具有化学稳定的无定形性质。含有这些优化的微球的凝胶与商业凝胶制剂相当,并且没有显示出严重的皮肤反应。因此,在最低药物/聚合物比下获得的微球系统可用于控制双氯芬酸钠向皮肤的释放。